AI Article Synopsis
- - Intracranial infantile hemangiomas are rare, with only 36 cases documented, and treatment methods have typically included surgery and steroids, with propranolol not being a standard option.
- - A one-month-old boy previously treated with propranolol for a supraclavicular hemangioma was found to have an associated intracranial hemangioma, identified through an MRI.
- - After two months of propranolol treatment, the boy's MRI showed a significant reduction in the size of the intracranial hemangioma, marking the first reported successful use of propranolol for this condition.
Article Abstract
Background: Intracranial infantile hemangiomas are extremely rare, with only 36 patients reported in literature. Treatment for intracranial infantile hemangiomas has been mostly limited to surgery, steroids, and interferon therapy. Propranolol, which is often used to treat cutaneous infantile hemangiomas, is not currently standard treatment for intracranial infantile hemangiomas.
Patient Description: We present a one-month old boy with an intracranial infantile hemangioma treated with propranolol.
Results: This boy was being treated with oral propranolol for a supraclavicular infantile hemangioma. Subsequent brain magnetic resonance imaging (MRI) scan showed evidence of an associated intracranial infantile hemangioma in the right cerebellopontine angle. Repeat brain MRI scan after two months of propranolol treatment demonstrated a significant reduction in the size of the intracranial infantile hemangioma.
Conclusions: This is the first report of successful therapy of an intracranial infantile hemangioma with propranolol.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pediatrneurol.2016.01.018 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!